314 related articles for article (PubMed ID: 21347238)
1. Aspirin treatment of mice infected with Trypanosoma cruzi and implications for the pathogenesis of Chagas disease.
Mukherjee S; Machado FS; Huang H; Oz HS; Jelicks LA; Prado CM; Koba W; Fine EJ; Zhao D; Factor SM; Collado JE; Weiss LM; Tanowitz HB; Ashton AW
PLoS One; 2011 Feb; 6(2):e16959. PubMed ID: 21347238
[TBL] [Abstract][Full Text] [Related]
2. Bioactive lipids in Trypanosoma cruzi infection.
Machado FS; Mukherjee S; Weiss LM; Tanowitz HB; Ashton AW
Adv Parasitol; 2011; 76():1-31. PubMed ID: 21884885
[TBL] [Abstract][Full Text] [Related]
3. Protective effect of aspirin treatment on mouse behavior in the acute phase of experimental infection with Trypanosoma cruzi.
Silvero-Isidre A; Morínigo-Guayuán S; Meza-Ojeda A; Mongelós-Cardozo M; Centurión-Wenninger C; Figueredo-Thiel S; Sanchez DF; Acosta N
Parasitol Res; 2018 Jan; 117(1):189-200. PubMed ID: 29196837
[TBL] [Abstract][Full Text] [Related]
4. Protective role of acetylsalicylic acid in experimental Trypanosoma cruzi infection: evidence of a 15-epi-lipoxin A₄-mediated effect.
Molina-Berríos A; Campos-Estrada C; Henriquez N; Faúndez M; Torres G; Castillo C; Escanilla S; Kemmerling U; Morello A; López-Muñoz RA; Maya JD
PLoS Negl Trop Dis; 2013; 7(4):e2173. PubMed ID: 23638194
[TBL] [Abstract][Full Text] [Related]
5. Aspirin prevents atrophy of esophageal nitrergic myenteric neurons in a mouse model of chronic Chagas disease.
Massocatto CL; Moreira NM; Muniz E; Pinge-Filho P; Rossi RM; Araújo EJ; Sant'Ana DM
Dis Esophagus; 2017 Feb; 30(2):1-8. PubMed ID: 26725535
[TBL] [Abstract][Full Text] [Related]
6. 4-aminopyridyl-based lead compounds targeting CYP51 prevent spontaneous parasite relapse in a chronic model and improve cardiac pathology in an acute model of Trypanosoma cruzi infection.
Calvet CM; Choi JY; Thomas D; Suzuki B; Hirata K; Lostracco-Johnson S; de Mesquita LB; Nogueira A; Meuser-Batista M; Silva TA; Siqueira-Neto JL; Roush WR; de Souza Pereira MC; McKerrow JH; Podust LM
PLoS Negl Trop Dis; 2017 Dec; 11(12):e0006132. PubMed ID: 29281643
[TBL] [Abstract][Full Text] [Related]
7. Myenteric neuroprotective role of aspirin in acute and chronic experimental infections with Trypanosoma cruzi.
Oda JY; Belém MO; Carlos TM; Gouveia R; Luchetti BFC; Moreira NM; Massocatto CL; Araújo SM; Sant Ana DMG; Buttow NC; Pinge-Filho P; Araújo EJA
Neurogastroenterol Motil; 2017 Oct; 29(10):1-13. PubMed ID: 28524628
[TBL] [Abstract][Full Text] [Related]
8. Cardioprotective actions of curcumin on the pathogenic NFAT/COX-2/prostaglandin E
Hernández M; Wicz S; Corral RS
Phytomedicine; 2016 Nov; 23(12):1392-1400. PubMed ID: 27765359
[TBL] [Abstract][Full Text] [Related]
9. Low-dose benznidazole treatment results in parasite clearance and attenuates heart inflammatory reaction in an experimental model of infection with a highly virulent Trypanosoma cruzi strain.
Cevey ÁC; Mirkin GA; Penas FN; Goren NB
Int J Parasitol Drugs Drug Resist; 2016 Apr; 6(1):12-22. PubMed ID: 26862474
[TBL] [Abstract][Full Text] [Related]
10. Physical Exercise Promotes a Reduction in Cardiac Fibrosis in the Chronic Indeterminate Form of Experimental Chagas Disease.
Pedra-Rezende Y; Barbosa JMC; Bombaça ACS; Dantas-Pereira L; Gibaldi D; Vilar-Pereira G; Dos Santos HAM; Ramos IP; Silva-Gomes NL; Moreira OC; Lannes-Vieira J; Menna-Barreto RFS
Front Immunol; 2021; 12():712034. PubMed ID: 34804007
[TBL] [Abstract][Full Text] [Related]
11. Trypanosoma cruzi: Inhibition of infection of human monocytes by aspirin.
Carvalho de Freitas R; Lonien SCH; Malvezi AD; Silveira GF; Wowk PF; da Silva RV; Yamauchi LM; Yamada-Ogatta SF; Rizzo LV; Bordignon J; Pinge-Filho P
Exp Parasitol; 2017 Nov; 182():26-33. PubMed ID: 28939444
[TBL] [Abstract][Full Text] [Related]
12. Curcumin Enhances the Anti-Trypanosoma cruzi Activity of Benznidazole-Based Chemotherapy in Acute Experimental Chagas Disease.
Novaes RD; Sartini MV; Rodrigues JP; Gonçalves RV; Santos EC; Souza RL; Caldas IS
Antimicrob Agents Chemother; 2016 Jun; 60(6):3355-64. PubMed ID: 27001816
[TBL] [Abstract][Full Text] [Related]
13. Aspirin modulates innate inflammatory response and inhibits the entry of Trypanosoma cruzi in mouse peritoneal macrophages.
Malvezi AD; da Silva RV; Panis C; Yamauchi LM; Lovo-Martins MI; Zanluqui NG; Tatakihara VL; Rizzo LV; Verri WA; Martins-Pinge MC; Yamada-Ogatta SF; Pinge-Filho P
Mediators Inflamm; 2014; 2014():580919. PubMed ID: 25045211
[TBL] [Abstract][Full Text] [Related]
14. Benznidazole alters the pattern of Cyclophosphamide-induced reactivation in experimental Trypanosoma cruzi-dependent lineage infection.
Santos DM; Martins TA; Caldas IS; Diniz LF; Machado-Coelho GL; Carneiro CM; Oliveira Rde P; Talvani A; Lana M; Bahia MT
Acta Trop; 2010 Feb; 113(2):134-8. PubMed ID: 19854145
[TBL] [Abstract][Full Text] [Related]
15. Thromboxane A2 is a key regulator of pathogenesis during Trypanosoma cruzi infection.
Ashton AW; Mukherjee S; Nagajyothi FN; Huang H; Braunstein VL; Desruisseaux MS; Factor SM; Lopez L; Berman JW; Wittner M; Scherer PE; Capra V; Coffman TM; Serhan CN; Gotlinger K; Wu KK; Weiss LM; Tanowitz HB
J Exp Med; 2007 Apr; 204(4):929-40. PubMed ID: 17420269
[TBL] [Abstract][Full Text] [Related]
16. Antiprotozoal drug nitazoxanide enhances parasitemia, tissue lesions and mortality caused by Trypanosoma cruzi in murine model.
Valle-Reyes JS; Melnikov V; Dobrovinskaya O; Rodriguez-Hernández A; Wookee-Zea C; Pimientel-Rodrigez V; Rueda-Valdovinos G; Delgado-Enciso I; López-Lemus UA; Espinoza-Gómez F
Exp Parasitol; 2017 Jan; 172():44-50. PubMed ID: 28011170
[TBL] [Abstract][Full Text] [Related]
17. Combination Therapy Using Benznidazole and Aspirin during the Acute Phase of Experimental Chagas Disease Prevents Cardiovascular Dysfunction and Decreases Typical Cardiac Lesions in the Chronic Phase.
Pereira RS; Malvezi AD; Lovo-Martins MI; Lucchetti BFC; Santos JP; Tavares ER; Verri WA; de Almeida Araújo EJ; Yamauchi LM; Yamada-Ogatta SF; Martins-Pinge MC; Pinge-Filho P
Antimicrob Agents Chemother; 2020 Jun; 64(7):. PubMed ID: 32366719
[TBL] [Abstract][Full Text] [Related]
18. Clomipramine and Benznidazole Act Synergistically and Ameliorate the Outcome of Experimental Chagas Disease.
García MC; Ponce NE; Sanmarco LM; Manzo RH; Jimenez-Kairuz AF; Aoki MP
Antimicrob Agents Chemother; 2016 Jun; 60(6):3700-8. PubMed ID: 27067322
[TBL] [Abstract][Full Text] [Related]
19. Trypanosoma cruzi: treatment with the iron chelator desferrioxamine reduces parasitemia and mortality in experimentally infected mice.
Arantes JM; Pedrosa ML; Martins HR; Veloso VM; de Lana M; Bahia MT; Tafuri WL; Carneiro CM
Exp Parasitol; 2007 Sep; 117(1):43-50. PubMed ID: 17521632
[TBL] [Abstract][Full Text] [Related]
20. Effects of homeopathy in mice experimentally infected with Trypanosoma cruzi.
de Almeida LR; Campos MC; Herrera HM; Bonamin LV; da Fonseca AH
Homeopathy; 2008 Apr; 97(2):65-9. PubMed ID: 18439966
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
